ResMed to buy back $450 million in stock under ASR
ResMed will buy back $450 million of stock under an accelerated share repurchase agreement with Citibank, using a 20 million-share repurchase authorization from 2014.
By Elias SchisgallResMed will buy back $450 million of its stock under an accelerated share repurchase agreement with Citibank.The buybacks are being made under a 20 million-share repurchase authorization from 2014, the medical equipment company said in a Tuesday regulatory filing.
The purchase wil…